How to lay out the grand curtain of the third quarter report after the festival?

category:Finance
 How to lay out the grand curtain of the third quarter report after the festival?


Before the festival, the share price of some pre issued shares in the third quarter has already performed. According to the disclosure rules of performance forecast, from the opening of the market after the festival to October 15, the third quarter report forecast will be more intensive, and the share prices of more companies will also change at this stage.

Electrical equipment and other industries have a high pre favor rate

According to the statistics of YueKai securities, according to the statistics of enterprises disclosed by various industries (Shenyi level industries), the pre gratification rates of agriculture, forestry, animal husbandry and fishery, electrical equipment, electronics, medicine, biology and national defense and military industry are higher, while those of commercial trade, leisure service, mining, transportation and media industries are lower.

In terms of the industry distribution of performance growth, according to the average value of the predicted growth rate disclosed, the companies whose net profit growth rate is more than 20% are mainly distributed in pharmaceutical biology, chemical industry, electrical equipment, electronics, mechanical equipment and computer industry. Investors may as well study the companies in the above industries that have not been pre increased, and the probability of hitting the pre increased shares is greater.

YueKai Securities believes that with the weak recovery of the economy in the second quarter of 2020, the profit expectation of the pro cyclical sector will also be weak improved. The industries with low valuation and large potential for profit improvement have higher cost performance ratio. It is suggested that attention should be paid to cement, aviation, and midstream raw materials and industrial products.

Tianfeng Securities believes that the market style in the fourth quarter of this year will be relatively balanced. On the one hand, there is a high probability that the pro cyclical liquor, white electricity, cement, chemical industry and aviation will have relative profits; on the other hand, it is suggested to pay attention to the military industry, photovoltaic, new energy vehicles, consumer electronics, engineering machinery, auto parts, production line equipment, etc., which can break out and continue in the third quarter.

Pharmaceutical sector is expected to return the king

Pharmaceutical sector stocks have generally experienced a substantial adjustment, short-term stock price risk has been released to a greater extent. Recently, a number of securities companies are optimistic about the third quarter of the pharmaceutical sector.

Wanlian Securities believes that the pharmaceutical sector has ushered in the allocation time point, and it is recommended to pay attention to the industrys third quarter report. There are four main lines

First, we should firmly believe in the high-quality track within the industry, lay out the innovative medicine and R & D industry chain (CXO) on a bargain basis, innovative medical devices benefiting from the new medical infrastructure, and high-quality individual stocks of medical services and consumption (growth hormone, medical rehabilitation and performance exceeding expectations).

Third, there are opportunities for the allocation of pharmaceutical stocks in the science and technology innovation board. After a period of market adjustment in the early stage, the high valuation risk of the short-term science and technology innovation board has been released. At the same time, with the recent implementation of related scientific and technological innovation 50 ETF products, the science and technology innovation board ushered in the allocation time point. It is suggested that attention should be paid to the pharmaceutical stocks of the scientific and technological innovation board with sufficient early adjustment and excellent fundamentals.

Fourth, the performance of some high-quality enterprises in the first half of the year had a slight impact, but since the second quarter, they have gradually entered a state of month on month improvement. Due to the low base effect in the same period of this year, some high growth stocks have ushered in medium and long-term allocation opportunities.

Southwest Securities is also optimistic about the third quarter growth of pharmaceutical stocks. It is suggested to continue to lay out high-profile plates such as vaccines, pharmacies, innovative pharmaceutical equipment and its industrial chain. Southwest Securities believes that the revenue and profits of the pharmaceutical sector have returned to a state of positive growth, especially the growth rate of pharmaceutical stocks on the science and technology innovation board is faster. From mid August to now, the adjustment range of pharmaceutical sector has reached more than 10%, and the adjustment range of some individual stocks has even reached more than 30%. In terms of valuation, the overall valuation of medicine has recovered to the level of July. Under the current background of good liquidity, the pharmaceutical sector has high performance certainty, good competition pattern and enjoys higher valuation premium. Huajin Securities believes that after more than one months adjustment, the valuation premium of the pharmaceutical sector has dropped significantly, and the valuation of some core leading companies has gradually returned. In addition, the recent repeated overseas epidemic situation and the smooth progress of new crown vaccine research and development are added. In the short term, it is recommended to pay attention to the sectors with good expectations of the third quarter report and those with obvious recovery and strong policy defense. The medium and long-term growth logic of medicine remains unchanged, and we continue to be optimistic about detection, vaccines, medical equipment and high-end consumables, integration of API preparations, innovative drugs and their industrial chain. Source: Yang Qian, editor in charge of Shanghai Securities News_ NF4425

Southwest Securities is also optimistic about the third quarter growth of pharmaceutical stocks. It is suggested to continue to lay out high-profile plates such as vaccines, pharmacies, innovative pharmaceutical equipment and its industrial chain. Southwest Securities believes that the revenue and profits of the pharmaceutical sector have returned to a state of positive growth, especially the growth rate of pharmaceutical stocks on the science and technology innovation board is faster. From mid August to now, the adjustment range of pharmaceutical sector has reached more than 10%, and the adjustment range of some individual stocks has even reached more than 30%. In terms of valuation, the overall valuation of medicine has recovered to the level of July. Under the current background of good liquidity, the pharmaceutical sector has high performance certainty, good competition pattern and enjoys higher valuation premium.

Huajin Securities believes that after more than one months adjustment, the valuation premium of the pharmaceutical sector has dropped significantly, and the valuation of some core leading companies has gradually returned. In addition, the recent repeated overseas epidemic situation and the smooth progress of new crown vaccine research and development are added. In the short term, it is recommended to pay attention to the sectors with good expectations of the third quarter report and those with obvious recovery and strong policy defense. The medium and long-term growth logic of medicine remains unchanged, and we continue to be optimistic about detection, vaccines, medical equipment and high-end consumables, integration of API preparations, innovative drugs and their industrial chain.